Literature DB >> 26203053

Correlation between cytotoxicity induced by Pseudomonas aeruginosa clinical isolates from acute infections and IL-1β secretion in a model of human THP-1 monocytes.

Ahalieyah Anantharajah1, Julien M Buyck1, Emmanuel Faure2, Youri Glupczynski3, Hector Rodriguez-Villalobos4, Daniel De Vos5, Jean-Paul Pirnay5, Florence Bilocq5, Benoît Guery2, Paul M Tulkens1, Marie-Paule Mingeot-Leclercq1, Françoise Van Bambeke6.   

Abstract

Type III secretion system (T3SS) in Pseudomonas aeruginosa is associated with poor clinical outcome in acute infections. T3SS allows for injection of bacterial exotoxins (e.g. ExoU or ExoS) into the host cell, causing cytotoxicity. It also activates the cytosolic NLRC4 inflammasome, activating caspase-1, inducing cytotoxicity and release of mature IL-1β, which impairs bacterial clearance. In addition, flagellum-mediated motility has been suggested to also modulate inflammasome response and IL-1β release. Yet the capacity of clinical isolates to induce IL-1β release and its relation with cytotoxicity have never been investigated. Using 20 clinical isolates from acute infections with variable T3SS expression levels and human monocytes, our aim was to correlate IL-1β release with toxin expression, flagellar motility and cytotoxicity. ExoU-producing isolates caused massive cell death but minimal release of IL-1β, while those expressing T3SS but not ExoU (i.e. expressing ExoS or no toxins) induced caspase-1 activation and IL-1β release, the level of which was correlated with cytotoxicity. Both effects were prevented by a specific caspase-1 inhibitor. Flagellar motility was not correlated with cytotoxicity or IL-1β release. No apoptosis was detected. Thus, T3SS cytotoxicity is accompanied by a modification in cytokine balance for P. aeruginosa clinical isolates that do not express ExoU. © FEMS 2015. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  ExoS; ExoU; TNF-alpha; flagellin; inflammasome; type three secretion system

Mesh:

Substances:

Year:  2015        PMID: 26203053      PMCID: PMC4626600          DOI: 10.1093/femspd/ftv049

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  19 in total

Review 1.  The type III secretion system as a source of novel antibacterial drug targets.

Authors:  Toni Kline; Heather B Felise; Sarah Sanowar; Samuel I Miller
Journal:  Curr Drug Targets       Date:  2012-03       Impact factor: 3.465

2.  Role of interleukin-1 in the pulmonary immune response during Pseudomonas aeruginosa pneumonia.

Authors:  Marc J Schultz; Anita W Rijneveld; Sandrine Florquin; Carl K Edwards; Charles A Dinarello; Tom van der Poll
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-02       Impact factor: 5.464

3.  Clinical outcomes of type III Pseudomonas aeruginosa bacteremia.

Authors:  Ali A El-Solh; Angela Hattemer; Alan R Hauser; Ahmad Alhajhusain; Hardik Vora
Journal:  Crit Care Med       Date:  2012-04       Impact factor: 7.598

4.  NLRC4 inflammasome-mediated production of IL-1β modulates mucosal immunity in the lung against gram-negative bacterial infection.

Authors:  Shanshan Cai; Sanjay Batra; Nobuko Wakamatsu; Pal Pacher; Samithamby Jeyaseelan
Journal:  J Immunol       Date:  2012-04-30       Impact factor: 5.422

5.  Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome.

Authors:  Edward A Miao; Dat P Mao; Natalya Yudkovsky; Richard Bonneau; Cynthia G Lorang; Sarah E Warren; Irina A Leaf; Alan Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-01       Impact factor: 11.205

6.  ExoS of Pseudomonas aeruginosa binds to a human KIF7 to induce cytotoxicity in cultured human bronchial epithelial cells.

Authors:  Jun Okuda; Asami Hanabusa; Naomasa Gotoh
Journal:  J Infect Chemother       Date:  2013-12-11       Impact factor: 2.211

7.  Flagellar motility is a key determinant of the magnitude of the inflammasome response to Pseudomonas aeruginosa.

Authors:  Yash R Patankar; Rustin R Lovewell; Matthew E Poynter; Jeevan Jyot; Barbara I Kazmierczak; Brent Berwin
Journal:  Infect Immun       Date:  2013-03-25       Impact factor: 3.441

8.  Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia.

Authors:  Grant S Schulert; Heather Feltman; Shira D P Rabin; Ciara G Martin; Scott E Battle; Jordi Rello; Alan R Hauser
Journal:  J Infect Dis       Date:  2003-11-21       Impact factor: 5.226

9.  Prevalence of type III secretion protein exoenzymes and antimicrobial susceptibility patterns from bloodstream isolates of patients with Pseudomonas aeruginosa bacteremia.

Authors:  K W Garey; Q P Vo; M T Larocco; L O Gentry; V H Tam
Journal:  J Chemother       Date:  2008-12       Impact factor: 1.714

10.  The Pseudomonas aeruginosa Type III secretion system plays a dual role in the regulation of caspase-1 mediated IL-1beta maturation.

Authors:  M Galle; P Schotte; M Haegman; A Wullaert; H J Yang; S Jin; R Beyaert
Journal:  J Cell Mol Med       Date:  2007-12-10       Impact factor: 5.310

View more
  8 in total

1.  ASC acts in a caspase-1-independent manner to worsen acute pneumonia caused by Pseudomonas aeruginosa.

Authors:  A J Hughes; C A Knoten; A R Morris; A R Hauser
Journal:  J Med Microbiol       Date:  2018-06-29       Impact factor: 2.472

Review 2.  NOD-like receptor(s) and host immune responses with Pseudomonas aeruginosa infection.

Authors:  Alaa Alhazmi
Journal:  Inflamm Res       Date:  2018-01-20       Impact factor: 4.575

3.  Salicylidene Acylhydrazides and Hydroxyquinolines Act as Inhibitors of Type Three Secretion Systems in Pseudomonas aeruginosa by Distinct Mechanisms.

Authors:  Ahalieyah Anantharajah; Julien M Buyck; Charlotta Sundin; Paul M Tulkens; Marie-Paule Mingeot-Leclercq; Françoise Van Bambeke
Journal:  Antimicrob Agents Chemother       Date:  2017-05-24       Impact factor: 5.191

4.  Immunomodulatory role for membrane vesicles released by THP-1 macrophages and respiratory pathogens during macrophage infection.

Authors:  Charlotte Volgers; Birke J Benedikter; Gert E Grauls; Paul H M Savelkoul; Frank R M Stassen
Journal:  BMC Microbiol       Date:  2017-11-13       Impact factor: 3.605

5.  Antimicrobial resistance and virulence of Pseudomonas spp. among healthy animals: concern about exolysin ExlA detection.

Authors:  Lidia Ruiz-Roldán; Beatriz Rojo-Bezares; María de Toro; María López; Paula Toledano; Carmen Lozano; Gabriela Chichón; Lydia Alvarez-Erviti; Carmen Torres; Yolanda Sáenz
Journal:  Sci Rep       Date:  2020-07-15       Impact factor: 4.379

Review 6.  Competitive Cell Death Interactions in Pulmonary Infection: Host Modulation Versus Pathogen Manipulation.

Authors:  Ethan S FitzGerald; Nivea F Luz; Amanda M Jamieson
Journal:  Front Immunol       Date:  2020-05-19       Impact factor: 7.561

7.  Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.

Authors:  Carmen Lozano; José Manuel Azcona-Gutiérrez; Françoise Van Bambeke; Yolanda Sáenz
Journal:  PLoS One       Date:  2018-09-13       Impact factor: 3.240

8.  The Pseudomonas aeruginosa protease LasB directly activates IL-1β.

Authors:  Josh Sun; Doris L LaRock; Elaine A Skowronski; Jacqueline M Kimmey; Joshua Olson; Zhenze Jiang; Anthony J O'Donoghue; Victor Nizet; Christopher N LaRock
Journal:  EBioMedicine       Date:  2020-09-23       Impact factor: 8.143

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.